These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 20333269)

  • 1. Advances in Nuclear Magnetic Resonance for Drug Discovery.
    Powers R
    Expert Opin Drug Discov; 2009 Oct; 4(10):1077-1098. PubMed ID: 20333269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR metabolomics and drug discovery.
    Powers R
    Magn Reson Chem; 2009 Dec; 47 Suppl 1():S2-11. PubMed ID: 19504464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of NMR and molecular docking in structure-based drug discovery.
    Stark JL; Powers R
    Top Curr Chem; 2012; 326():1-34. PubMed ID: 21915777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of drug discovery and a potential role for NMR metabolomics.
    Powers R
    J Med Chem; 2014 Jul; 57(14):5860-70. PubMed ID: 24588729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR in the acceleration of drug discovery.
    Sem DS; Pellecchia M
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomolecular NMR: a chaperone to drug discovery.
    Betz M; Saxena K; Schwalbe H
    Curr Opin Chem Biol; 2006 Jun; 10(3):219-25. PubMed ID: 16679046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR Metabolomics Protocols for Drug Discovery.
    Bhinderwala F; Powers R
    Methods Mol Biol; 2019; 2037():265-311. PubMed ID: 31463851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multidisciplinary Approach to High Throughput Nuclear Magnetic Resonance Spectroscopy.
    Pourmodheji H; Ghafar-Zadeh E; Magierowski S
    Sensors (Basel); 2016 Jun; 16(6):. PubMed ID: 27294925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.
    Ziarek JJ; Peterson FC; Lytle BL; Volkman BF
    Methods Enzymol; 2011; 493():241-75. PubMed ID: 21371594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution NMR Spectroscopy in Target-Based Drug Discovery.
    Li Y; Kang C
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832542
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kang C
    Curr Med Chem; 2019; 26(26):4964-4983. PubMed ID: 31187703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
    Mureddu LG; Vuister GW
    Front Mol Biosci; 2022; 9():834453. PubMed ID: 35252355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A drug discovery toolbox for Nuclear Magnetic Resonance (NMR) characterization of ligands and their targets.
    LeBlanc RM; Mesleh MF
    Drug Discov Today Technol; 2020 Dec; 37():51-60. PubMed ID: 34895655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes.
    Dias DM; Ciulli A
    Prog Biophys Mol Biol; 2014; 116(2-3):101-12. PubMed ID: 25175337
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.